Vietnam Diagnostic Tests Market Research Report: Forecast (2026-2032)

By Test Type (Immunoassay-based diagnostic tests, Molecular diagnostic tests (PCR, NAAT, FISH, NGS), Clinical chemistry tests, Hematology tests, Microbiology & culture-based tests, Coagulation tests,... ... Coagulation tests, Others), By End User (Hospital-based laboratories (public & private hospitals), Independent diagnostic laboratories, Clinics & physician offices, Home care & self-testing (POCT-based use), Public health & government laboratories, Research & academic laboratories), By Disease Application (Infectious Diseases, Oncology, Cardiovascular Diseases, Diabetes & Metabolic Disorders, Women's Health & Reproductive Health, Autoimmune & Neurological Disorders, Others), and others Read more

  • Healthcare
  • Jun 2026
  • 140
  • PDF, Excel, PPT

Vietnam Diagnostic Tests Market Key Takeaways

  • The Vietnam Diagnostic Tests Market is valued at USD 1.68 billion in 2025 and is projected to reach USD 1.91 billion by 2026 and USD 3.13 billion by 2032.
  • The industry is projected to witness steady growth at a CAGR of 8.59% during 2026–2032.
  • Immunoassay-Based Diagnostic Tests lead the market by test technology, accounting for approximately 30% of total market revenue in 2026.
  • Infectious Diseases represent the largest disease application segment, contributing approximately 32% of the market in 2026.
  • The market remains moderately fragmented, with the top five companies accounting for approximately 39% of total market share in 2026.

Vietnam Diagnostic Tests Market Size & Outlook

The Vietnam Diagnostic Tests Market was valued at USD 1.68 Billion in 2025 and is projected to reach USD 1.91 Billion in 2026 and USD 3.13 Billion by 2032, expanding at a CAGR of 8.59% during 2026–2032.

Market growth is being supported by the rising burden of chronic and infectious diseases, increasing healthcare investments, and expanding access to healthcare services across the country. Growing emphasis on preventive healthcare and early disease identification is encouraging greater utilization of diagnostic screening solutions across hospitals, laboratories, and outpatient care settings.

Vietnam’s changing disease landscape continues to create strong demand for testing services. In 2025, the country recorded 181,200 dengue cases and 43 deaths in 2025, representing a 33% increase in cases and 17 additional deaths compared with 2024. The increasing need for disease monitoring, risk assessment, and treatment management is driving testing volumes nationwide. These healthcare trends are supporting the expansion of the medical diagnostics industry and encouraging healthcare providers to strengthen their diagnostic capabilities through advanced testing technologies.

The market is also benefiting from healthcare modernization initiatives and rapid digital transformation. The implementation of the Law on Medical Examination and Treatment (2024) and the expansion of electronic medical records are improving healthcare connectivity and patient data management. At the same time, hospitals and laboratories are investing in automation technologies, advanced imaging equipment, and molecular testing platforms to improve efficiency and diagnostic accuracy. These developments are accelerating the adoption of healthcare testing technologies throughout Vietnam’s healthcare ecosystem.

Furthermore, increasing investments by multinational diagnostic companies and healthcare institutions are enhancing the country's testing infrastructure. The deployment of artificial intelligence-enabled imaging systems, automated laboratory workflows, and advanced molecular diagnostic platforms is improving service quality and operational efficiency. While infrastructure disparities remain in some provincial regions, continued government support and technology adoption are expected to create favorable conditions for long-term market growth and further expansion of Vietnam’s diagnostic testing industry.

Vietnam Diagnostic Tests Market Key Indicators

  • According to the WHO Global Tuberculosis Report 2024, Vietnam recorded over 113,000 tuberculosis cases in 2024, with an estimated incidence rate of around 182 cases per 100,000 population, placing the country among high TB-burden nations. This persistent TB prevalence is driving strong demand for molecular diagnostic testing solutions and strengthening infectious disease diagnostics capacity across Vietnam’s healthcare system.
  • According to the U.S. International Trade Administration (2025), Vietnam’s medical device market was valued at approximately USD 1.9 billion in 2024, with around 90% of medical equipment supplied through imports. The large installed base of imported medical technologies, including diagnostic and laboratory equipment, highlights the country’s increasing reliance on advanced testing infrastructure and modernization of healthcare facilities.
  • According to the Ministry of Health of Vietnam, cited by Vietnam Briefing (2025), the domestic medical equipment market reached nearly USD 1.7 billion in 2024 and has maintained strong growth driven by healthcare modernization initiatives. Continued investments in hospital equipment, laboratory systems, and healthcare infrastructure create a favourable environment for the expansion of diagnostic capabilities nationwide.
  • According to the International Agency for Research on Cancer (IARC), Vietnam recorded 180,480 new cancer cases in the latest available national assessment. The growing burden of oncology cases requires extensive use of screening, pathology, molecular testing, and disease-monitoring services, increasing the demand for diagnostic procedures across the care continuum.
  • According to Vietnam’s Ministry of Health surveillance data (2024–2025), the country continues to report a high burden of infectious diseases, including dengue fever, measles, and hand, foot, and mouth disease. Dengue cases exceeded 200,000 in 2025, while over 70,000 hand, foot, and mouth disease cases were recorded in 2024, highlighting persistent outbreak cycles. This sustained disease burden is increasing demand for diagnostic screening solutions and strengthening clinical diagnostics capacity across Vietnam’s healthcare system

Vietnam Diagnostic Tests Market Scope

 Category  Segments
By Test Type Immunoassay-based diagnostic tests, Molecular diagnostic tests (PCR, NAAT, FISH, NGS), Clinical chemistry tests, Hematology tests, Microbiology & culture-based tests, Coagulation tests, Others
By End User Hospital-based laboratories (public & private hospitals), Independent diagnostic laboratories, Clinics & physician offices, Home care & self-testing (POCT-based use), Public health & government laboratories, Research & academic laboratories
By Disease Application Infectious Diseases, Oncology, Cardiovascular Diseases, Diabetes & Metabolic Disorders, Women's Health & Reproductive Health, Autoimmune & Neurological Disorders, Others

Vietnam Diagnostic Tests Market Drivers

Increasing Prevalence of Chronic Diseases Driving Demand for Diagnostic Testing Services

The Vietnam Diagnostic Tests Market is experiencing strong growth due to the increasing prevalence of chronic diseases, which is driving the need for early detection, disease monitoring, and preventive healthcare services. According to the International Diabetes Federation, approximately 7 million individuals were living with diabetes in Vietnam in 2024, while the Vietnam National Heart Association estimates that nearly 12 million people suffer from hypertension. The growing burden of cardiovascular disorders, metabolic diseases, chronic kidney disease, and liver-related conditions continues to increase the volume of routine testing and follow-up monitoring conducted across healthcare facilities nationwide.

The rising incidence of cancer in Vietnam is significantly increasing demand for advanced diagnostic procedures such as pathology testing, biomarker analysis, and molecular diagnostics. In addition, cardiovascular diseases remain the leading cause of mortality, accounting for nearly 30% of total deaths annually, highlighting the growing clinical need for continuous monitoring and early detection. Furthermore, chronic kidney disease affects around 12% of the population as of 2024, reinforcing the importance of timely and accurate diagnostic evaluation for effective treatment planning. Collectively, the increasing burden of chronic and age-related diseases is driving the expansion of diagnostic screening solutions and strengthening the adoption of clinical diagnostics across Vietnam’s healthcare system.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Vietnam Diagnostic Tests Market Policies, Regulations, and Product Standards
  5. Vietnam Diagnostic Tests Market Trends & Developments
  6. Vietnam Diagnostic Tests Market Dynamics
    1. Growth Factors
    2. Challenges
  7. Vietnam Diagnostic Tests Market Hotspot & Opportunities
  8. Vietnam Diagnostic Tests Market Outlook, 2022-2032F
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Test Type- Market Size & Forecast 2022-2032, USD Million
        1. Immunoassay-based diagnostic tests
        2. Molecular diagnostic tests (PCR, NAAT, FISH, NGS)
        3. Clinical chemistry tests
        4. Hematology tests
        5. Microbiology & culture-based tests
        6. Coagulation tests
        7. Others
      2. By End User- Market Size & Forecast 2022-2032, USD Million
        1. Hospital-based laboratories (public & private hospitals)
        2. Independent diagnostic laboratories
        3. Clinics & physician offices
        4. Home care & self-testing (POCT-based use)
        5. Public health & government laboratories
        6. Research & academic laboratories
      3. By Disease Application
        1. Infectious Diseases
        2. Oncology
        3. Cardiovascular Diseases
        4. Diabetes & Metabolic Disorders
        5. Women's Health & Reproductive Health
        6. Autoimmune & Neurological Disorders
        7. Others
      4. By Region- Market Size & Forecast 2022-2032, USD Million
        1. Northern Vietnam
        2. Central Vietnam
        3. Southern Vietnam
      5. By Company
        1. Competition Characteristics
        2. Market Share & Analysis
  9. Vietnam Immunoassay-based Diagnostic Tests Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Application- Market Size & Forecast 2022-2032, USD Million
      2. By End User- Market Size & Forecast 2022-2032, USD Million
      3. By Region- Market Size & Forecast 2022-2032, USD Million
  10. Vietnam Molecular Diagnostic Tests Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Application- Market Size & Forecast 2022-2032, USD Million
      2. By End User- Market Size & Forecast 2022-2032, USD Million
      3. By Region- Market Size & Forecast 2022-2032, USD Million
  11. Vietnam Clinical Chemistry Tests Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Application- Market Size & Forecast 2022-2032, USD Million
      2. By End User- Market Size & Forecast 2022-2032, USD Million
      3. By Region- Market Size & Forecast 2022-2032, USD Million
  12. Vietnam Hematology Tests Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Application- Market Size & Forecast 2022-2032, USD Million
      2. By End User- Market Size & Forecast 2022-2032, USD Million
      3. By Region- Market Size & Forecast 2022-2032, USD Million
  13. Vietnam Microbiology & Culture-Based Tests Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Application- Market Size & Forecast 2022-2032, USD Million
      2. By End User- Market Size & Forecast 2022-2032, USD Million
      3. By Region- Market Size & Forecast 2022-2032, USD Million
  14. Vietnam Diagnostic Tests Market Key Strategic Imperatives for Success & Growth
  15. Competitive Outlook
    1. Company Profiles
      1. Coagulation tests
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Roche Vietnam Company Limited
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Siemens Healthcare Limited Company
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Abbott Laboratories GmbH (Vietnam)
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Becton, Dickinson and Company (BD Vietnam)
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Thermo Fisher Scientific (Vietnam)
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Bio-Rad Laboratories, Inc. (Vietnam presence)
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Medtronic Vietnam Company Limited
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Viet A Technologies JSC
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Medicon JSC
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
  16. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .